Literature DB >> 6390559

Neuropsychology of alcoholism. Etiology, phenomenology, process, and outcome.

R E Tarter, C M Ryan.   

Abstract

A number of empirical and conceptual issues are addressed in an effort to explain the diversity of neuropsychological deficits demonstrated by chronic alcoholics. In addition to consumption characteristics and the neurotoxic effects of ethanol, evidence is marshalled to implicate nutritional deficiency, hepatic disease, congeners in the beverage, and cognitive regression as also being contributory to the manifest impairments. Moreover, predrinking disturbances are considered that may be responsible in part for the neuropsychological deficits observed in chronic alcoholics. Our understanding of the neuropsychological concomitants of alcoholism can be increased by the adoption of a life-span approach to alcohol effects, localizing the system or region of maximal cerebral damage and relating these findings to treatment intervention. The extent to which adaptive capacity in alcoholics and social drinkers is predicted by neuropsychological test performance is of utmost importance, especially since nonalcoholic social drinkers also demonstrate a number of impairments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6390559

Source DB:  PubMed          Journal:  Recent Dev Alcohol        ISSN: 0738-422X


  10 in total

Review 1.  Experience-dependent neuropsychological recovery and the treatment of chronic alcoholism.

Authors:  M S Goldman
Journal:  Neuropsychol Rev       Date:  1990-03       Impact factor: 7.444

2.  Older adult patients with both psychiatric and substance abuse disorders: prevalence and health service use.

Authors:  H G Prigerson; R A Desai; R A Rosenheck
Journal:  Psychiatr Q       Date:  2001

3.  Improvement in memory and static balance with abstinence in alcoholic men and women: selective relations with change in brain structure.

Authors:  Margaret J Rosenbloom; Torsten Rohlfing; Anne W O'Reilly; Stephanie A Sassoon; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Psychiatry Res       Date:  2007-04-03       Impact factor: 3.222

4.  Reduced resource optimization in male alcoholics: N400 in a lexical decision paradigm.

Authors:  Bangalore N Roopesh; Madhavi Rangaswamy; Chella Kamarajan; David B Chorlian; Ashwini K Pandey; Bernice Porjesz
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

5.  Differentiating Individuals with and without Alcohol Use Disorder Using Resting-State fMRI Functional Connectivity of Reward Network, Neuropsychological Performance, and Impulsivity Measures.

Authors:  Chella Kamarajan; Babak A Ardekani; Ashwini K Pandey; Sivan Kinreich; Gayathri Pandey; David B Chorlian; Jacquelyn L Meyers; Jian Zhang; Elaine Bermudez; Weipeng Kuang; Arthur T Stimus; Bernice Porjesz
Journal:  Behav Sci (Basel)       Date:  2022-04-28

6.  White matter integrity in adolescents with histories of marijuana use and binge drinking.

Authors:  J Jacobus; T McQueeny; S Bava; B C Schweinsburg; L R Frank; T T Yang; S F Tapert
Journal:  Neurotoxicol Teratol       Date:  2009-07-23       Impact factor: 3.763

Review 7.  Dual diagnosis.

Authors:  M F Sheehan
Journal:  Psychiatr Q       Date:  1993

Review 8.  Cognitive rehabilitation of chronic alcohol abusers.

Authors:  D N Allen; G Goldstein; B E Seaton
Journal:  Neuropsychol Rev       Date:  1997-03       Impact factor: 7.444

9.  Random Forest Classification of Alcohol Use Disorder Using EEG Source Functional Connectivity, Neuropsychological Functioning, and Impulsivity Measures.

Authors:  Chella Kamarajan; Babak A Ardekani; Ashwini K Pandey; David B Chorlian; Sivan Kinreich; Gayathri Pandey; Jacquelyn L Meyers; Jian Zhang; Weipeng Kuang; Arthur T Stimus; Bernice Porjesz
Journal:  Behav Sci (Basel)       Date:  2020-03-01

10.  Impaired fear recognition and attentional set-shifting is associated with brain structural changes in alcoholic patients.

Authors:  Leanne Trick; Matthew J Kempton; Steven C R Williams; Theodora Duka
Journal:  Addict Biol       Date:  2014-08-06       Impact factor: 4.280

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.